Literature DB >> 21554912

Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses.

Christelle Liard1, Séverine Munier, Mauricio Arias, Alix Joulin-Giet, Olivia Bonduelle, Darragh Duffy, Robin J Shattock, Bernard Verrier, Behazine Combadière.   

Abstract

Skin routes of immunization such as subcutaneous (SC), intradermal (ID) and transcutaneous (TC) administration are utilized for vaccination against various pathogens, without understanding their potential impact on the outcome of immune responses. We demonstrated that SC immunization induced HIV-1 p24 specific IgG in absence of antigen-specific CD8 T cells, whereas the ID route induced both cellular and humoral responses. Interestingly, TC application through empty hair follicular ducts, targeting epidermal Langerhans Cells (LCs), induced major CD8 effector cells, in the absence of IgG. However, high levels of mucosal IgA, were localized in the stratified epithelium of the vagina after TC prime. We propose that re-directing the immune responses by targeting differential skin immunization routes, offers enormous potential for innovative vaccination strategies, especially against HIV.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554912     DOI: 10.1016/j.vaccine.2011.04.080

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Induction of mucosal immunity through systemic immunization: Phantom or reality?

Authors:  Fei Su; Girishchandra B Patel; Songhua Hu; Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

Review 2.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

3.  Comparison of Models for Bubonic Plague Reveals Unique Pathogen Adaptations to the Dermis.

Authors:  Rodrigo J Gonzalez; Eric H Weening; M Chelsea Lane; Virginia L Miller
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

Review 4.  Tailored immunity by skin antigen-presenting cells.

Authors:  Clement Levin; Helene Perrin; Behazine Combadiere
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

5.  Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination.

Authors:  Eléna Gonçalves; Olivia Bonduelle; Angèle Soria; Pierre Loulergue; Alexandra Rousseau; Marine Cachanado; Henri Bonnabau; Rodolphe Thiebaut; Nicolas Tchitchek; Sylvie Behillil; Sylvie van der Werf; Annika Vogt; Tabassome Simon; Odile Launay; Behazine Combadière
Journal:  J Clin Invest       Date:  2019-03-07       Impact factor: 14.808

Review 6.  Nanocarriers for Skin Applications: Where Do We Stand?

Authors:  Neha Tiwari; Ernesto Rafael Osorio-Blanco; Ana Sonzogni; David Esporrín-Ubieto; Huiyi Wang; Marcelo Calderón
Journal:  Angew Chem Int Ed Engl       Date:  2021-10-01       Impact factor: 16.823

7.  Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.

Authors:  Franco Pissani; Bianca Schulte; Michael A Eller; Bruce T Schultz; Silvia Ratto-Kim; Mary Marovich; Prasert Thongcharoen; Somchai Sriplienchan; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Stefan Esser; Galit Alter; Merlin L Robb; Jerome H Kim; Nelson L Michael; Hendrik Streeck
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

8.  Potent induction of antibody-secreting B cells by human dermal-derived CD14+ dendritic cells triggered by dual TLR ligation.

Authors:  Katie Matthews; Nancy P Y Chung; Per Johan Klasse; John P Moore; Rogier W Sanders
Journal:  J Immunol       Date:  2012-11-16       Impact factor: 5.422

Review 9.  Predictive Markers of Immunogenicity and Efficacy for Human Vaccines.

Authors:  Matthieu Van Tilbeurgh; Katia Lemdani; Anne-Sophie Beignon; Catherine Chapon; Nicolas Tchitchek; Lina Cheraitia; Ernesto Marcos Lopez; Quentin Pascal; Roger Le Grand; Pauline Maisonnasse; Caroline Manet
Journal:  Vaccines (Basel)       Date:  2021-06-01

10.  Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells.

Authors:  Katie Matthews; Nancy P Y Chung; Per Johan Klasse; Magda Moutaftsi; Darrick Carter; André M Salazar; Steven G Reed; Rogier W Sanders; John P Moore
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.